Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: Is cure possible in a small subgroup?

Journal of Clinical Oncology

Volumn 9, Issue 6, 1991, Pages 1037-1044

  Philip, T ^a   Zucker, J M ^a   Bernard, J L ^a   Lutz, P ^a   Bordigoni, P ^a   Plouvier, E ^a   Robert, A ^a   Roche, H ^a   Souillet, G ^a   Bouffet, E ^a   Michon, J ^a   Lopez, M ^a   Vilcoq, J M ^a   Gentet, J C ^a   Philip, I ^a   Ladenstein, R ^a   Favrot, M ^a   Chauvin, F ^a  

^a CENTRE LÉON BÉRARD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; TENIPOSIDE; VINCRISTINE;

ADOLESCENT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CHILDHOOD CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; PRIORITY JOURNAL; SURVIVAL;

EID: 0025774190     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1991.9.6.1037     Document Type: Article

References (0)